Presentations PDF Print E-mail

Please find here 

the Critical Issues 2018 preliminary programme Critical Issues 2018 final programme  

for download. 

All authorized presentations are now available for download.

The download will start automatically once you click on the selected presentation.

 

 

ci18_banner_web.jpg 
     
     
   

FRIDAY JUNE 29

     
07:30   Registration and coffee

08:00

  Welcome   Tim Resch, Nuno Dias, Björn Sonesson
     
     

08:10

  Session 1: Progressive aortic disease
    Moderators: T. Mastracci, I. Loftus
     
08:10   Case introduction  T. Mastracci 
08:22   Biomarkers for aortic degeneration, cell inflammation with radiological signs of disease     A. Edsfeldt
08:29   How does sealing technology impact aortic neck dilatation compared to standard EVAR and is this clinically relevant?     I. Loftus
08:36   What is the evidence that a longer sealing zone is really needed toachieve EVAR durability?     
T. Mastracci
08:43   Adverse sealing zone features and impact on outcome     F. Bastos Gonçalves
08:50   CTD – update and implications for therapy?     G. Oderich
08:57   Type 1EL – what is the best Tx?     N. Dias 
     
09:04 | Discussion 
     
     
09:46   Coffee break and visit of industry exhibit 
     
     

10:15

  Session 2: Arch repair
    Moderators: M. Jacobs, L. Mendes Pedro
     
10:15   Case introduction:     N. Tsilimparis
10:27   Intraoperative pressure control with endovascular ascending and arch repair     S. Cheng
10:34   Ascending endovascular repair to create a Zone 0 landing zone     N. Tsilimparis
10:41   Optimizing open Type A dissection repair technique     M. Jacobs
10:48   What is the role of in-situ fenestrations in the arch     B. Sonesson 
10:55   The ultimate method for LSA revascularization – how should we choose?     M. Gargiulo 
11:02   Low flow type 1EL after chArch repair – definition and why they don’t matter     M. Malina 
11:09   How to choose which arch repair type – open/branch/fenestrated/CHIMP     E. Verhoeven 
     
11:16 | Discussion
     
     
11:45   Lunch and visit of industry exhibit 
     
     

13:00 

  Session 3: Radiation challenges
    Moderators: M. Eagleton, B. Modarai
     
13:00   Case introduction     B. Modarai
13:12   Predicting SG deformation with advanced imaging     M. Falkenberg
13:19   CO2 angiography – dead or alive?     N. Dias
13:26   Blood markers for radiation damage and effects of chronic exposure     B. Modarai
13:33    Total percutaneous access and closure of the axillary/subclavian artery during complex EVAR – advantages and drawbacks     G. Melissano 
13:40   Fusion and CBCT are essential to reduce exposure during complex EVAR     E. Verhoeven
13:47   Stop arguing – radiation will be no issue in the future – IOPS     M. Eagleton 
     
13:54 |  Discussion 
     
     

14:20

 

CI Honorary lecture 

    Long term outcomes after EVAR – why are the results from the US and European trials not aligned?     
R. Greenhalgh 
     
     

14:35

  Session 4: Aortic dissection
    Moderators: B. Sonesson, C.-M. Wahlgren
     
14:35   Case introduction     T. Butt
14:46   How to plan appropriately for treating acute dissections     N. Tsilimparis
14:53   Timing for treatment of acute dissections     I. Loftus
15:05   TEVAR only for CD – when does it work?     C.-M. Wahlgren
15:12   Is there a role for false lumen occlusion for CD     M. A. Farber 
15:19   When to use fenestrations, inner branches, or int/ext branches for CD     M. Ferreira 
15:26   Endovascular Tx of chronic dissection – planning, technique, and pitfalls     P. Kasprzak
15:33   3D imaging to perform and evaluate F/BEVAR for dissection repair     M. Eagleton 
     
15:40 | Discussion
     
     
16:15   Coffee break and visit of industry exhibit
     
     

16:40

  Session 5: Mycotic aneurysm and stentgraft infection
    Moderators: T. Resch, E. Verhoeven
     
16:40    Case introduction     J. Hasselmann
16:52   Endovascular treatment for mycotic aneurysms – what are the culprit
organisms and does it matter for management? 
    A. Wanhainen
16:59   How do we best investigate a suspected graft infection?     J. Brennan
17:06   Semi-conservative treatment is the new gold standard     B. Sonesson
17:13   Explantation of TEVAR – best replacement technique     G. Melissano
     
17:20 |  Discussion 
   
     
     
     
ci18_banner_web.jpg
     
     
   

SATURDAY JUNE 30

08:00   Welcome and coffee
     

08:45 

 

Breakfast session

    partially supported with an educational grant by GE Healthcare 
    Moderators: T. Resch, G. Oderich 
08:45    EVAR and renal failure     N. Dias
08:55    Iodinated contrast and the kidney: have we overestimated the impact of kidney infury?     
R. Solomon
     
09:10 Discussion 
     
     

09:30 

 

Session 6: Juxtarenal challenges 

    Moderators: G. Oderich, M. A. Farber     
     
09:30   Case introduction     M. A. Farber
09:42   Stick with what you know – how to use standard infrarenal SG for short neck aneurysm     H. Verhagen
09:49   Can we use a standard stentgraft but fixate it with endostaplers?     M. Jenkins
09:56   Open repair for juxtarenal aneurysms – contemporary outcomes     S. Debus
10:03   Chimneys are the go-to OTS solution – which graft/stent combination is optimal?     K. Donas
10:10  

Fenestrated stentgrafts are the only proven option with good outcomes     A. Katsargyris

10:17   Not all fenestrated grafts are the same – choosing the right one for the right patient     J. Brunkwall
10:24   The choice of mating stents is critical for simplifying FEVAR and creating long-term success     
M. Eagleton 
10:31    Performance of different bridging stent grafts in a fenestrated model after flairing. A in vitro study.   
M. Austermann 
     
10:38 | Discussion
     
     
11:00   Coffee break and visit of the industry exhibit 
     
     

11:30

  Session 7: Visceral segment involvement
    Moderators: N. Dias, S.R. Vallabhaneni
     
11:30   Case introduction     R. Vaccarino
11:42   Off the shelf designs for TAAA – are they all really the same?     G. Oderich
11:49   P BRANCH vs chimney vs PMD(US,) for type 4 TAAA     M. A. Farber
11:56   Why would a multimodular device be better for TAAA than current designs?     T. Maldonado
12:04   In situ repair for TAAA – techniques and outcomes     D. Fabre
12:11   Don‘t use more than 2 chimneys!     N. Mosquera
12:18   Why choose a CHIMP when you can have an approved device?     S. R. Vallabhaneni
12:25   Spinal cord protection is mandatory but should be used selectively     G.W.H. Schurink 
     
12:32 |  Discussion 
     
     

 
13:00   Light lunch and adjourn